Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review

Molecular Neurobiology

Volumn 55, Issue 6, 2018, Pages 5075-5100

  Misiak, Błażej ^a   Stramecki, Filip ^a   Gawęda, Łukasz ^b,c   Prochwicz, Katarzyna ^d   Sąsiadek, Maria M ^a   Moustafa, Ahmed A ^e   Frydecka, Dorota ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d JAGIELLONIAN UNIVERSITY   (Poland)

^e WESTERN SYDNEY UNIVERSITY   (Australia)

Author keywords

Bipolarity; Gene polymorphism; Gene environment interaction; Psychosis

Indexed keywords

BDNF GENE; BIPOLAR DISORDER; CANNABIS ADDICTION; COMT GENE; EARLY LIFE STRESS; ENVIRONMENTAL FACTOR; FKBP5 GENE; GENE; GENE INTERACTION; GENETIC VARIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PHENOTYPE; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; ENVIRONMENT; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS;

BIPOLAR DISORDER; ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; SCHIZOPHRENIA;

EID: 85027704866     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-017-0708-y     Document Type: Review

References (174)

1. Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97(1):12–17
2. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A (2003) The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60(5):497–502. doi:10.1001/archpsyc.60.5.497
3. Misiak B, Frydecka D, Rybakowski JK (2016) Editorial: endophenotypes for schizophrenia and mood disorders: implications from genetic, biochemical, cognitive, behavioral, and neuroimaging studies. Front Psych 7:83. doi:10.3389/fpsyt.2016.00083
4. Ripke S, Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421–427. doi:10.1038/nature13595
5. Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43 (10):977–983. doi:10.1038/ng.943
6. Agerbo E, Sullivan PF, Vilhjalmsson BJ, Pedersen CB, Mors O, Borglum AD, Hougaard DM, Hollegaard MV et al (2015) Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia: a Danish population-based study and meta-analysis. JAMA Psychiat 72(7):635–641. doi:10.1001/jamapsychiatry.2015.0346
7. Kotlar AV, Mercer KB, Zwick ME, Mulle JG (2015) New discoveries in schizophrenia genetics reveal neurobiological pathways: a review of recent findings. Eur J Med Genet 58(12):704–714. doi:10.1016/j.ejmg.2015.10.008
8. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A et al (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45(9):984–994. doi:10.1038/ng.2711
9. Van Snellenberg JX, de Candia T (2009) Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry 66(7):748–755. doi:10.1001/archgenpsychiatry.2009.64
10. Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA, Tamminga CA, Clementz BA et al (2013) Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry 170(8):886–898. doi:10.1176/appi.ajp.2013.12111448
11. Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD et al (2013) Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry 170(11):1275–1284. doi:10.1176/appi.ajp.2013.12101298
12. Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD et al (2015) Large-scale fusion of gray matter and resting-state functional MRI reveals common and distinct biological markers across the psychosis spectrum in the B-SNIP Cohort. Front Psych 6:174. doi:10.3389/fpsyt.2015.00174
13. Cardno AG, Owen MJ (2014) Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull 40(3):504–515. doi:10.1093/schbul/sbu016
14. Marangoni C, Hernandez M, Faedda GL (2016) The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies. J Affect Disord 193:165–174. doi:10.1016/j.jad.2015.12.055
15. Dean K, Murray RM (2005) Environmental risk factors for psychosis. Dialogues Clin Neurosci 7(1):69–80
16. van Os J, Rutten BP, Poulton R (2008) Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 34(6):1066–1082. doi:10.1093/schbul/sbn117
17. Ayhan Y, McFarland R, Pletnikov MV (2016) Animal models of gene-environment interaction in schizophrenia: a dimensional perspective. Prog Neurobiol 136:1–27. doi:10.1016/j.pneurobio.2015.10.002
18. Ottman R (1996) Gene-environment interaction: definitions and study designs. Prev Med 25(6):764–770
19. Modinos G, Iyegbe C, Prata D, Rivera M, Kempton MJ, Valmaggia LR, Sham PC, van Os J et al (2013) Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review. Schizophr Res 150(2–3):356–365. doi:10.1016/j.schres.2013.09.010
20. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. doi:10.1136/bmj.b2535
21. de Castro-Catala M, van Nierop M, Barrantes-Vidal N, Cristobal-Narvaez P, Sheinbaum T, Kwapil TR, Pena E, Jacobs N et al (2016) Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples. J Psychiatr Res 83:121–129. doi:10.1016/j.jpsychires.2016.08.014
22. Cristobal-Narvaez P, Sheinbaum T, Rosa A, Ballespi S, de Castro-Catala M, Pena E, Kwapil TR, Barrantes-Vidal N (2016) The interaction between childhood bullying and the FKBP5 gene on psychotic-like experiences and stress reactivity in real life. PLoS One 11(7):e0158809. doi:10.1371/journal.pone.0158809
23. Barrantes-Vidal N, Chun CA, Myin-Germeys I, Kwapil TR (2013) Psychometric schizotypy predicts psychotic-like, paranoid, and negative symptoms in daily life. J Abnorm Psychol 122(4):1077–1087. doi:10.1037/a0034793
24. Gattere G, Stojanovic-Perez A, Monseny R, Martorell L, Ortega L, Montalvo I, Sole M, Algora MJ et al (2016) Gene-environment interaction between the brain-derived neurotrophic factor Val66Met polymorphism, psychosocial stress and dietary intake in early psychosis. Early Interv Psychiatry. doi:10.1111/eip.12371
25. Mandelli L, Toscano E, Porcelli S, Fabbri C, Serretti A (2016) Age of onset in schizophrenia Spectrum disorders: complex interactions between genetic and environmental factors. Psychiatry Investig 13(2):247–249. doi:10.4306/pi.2016.13.2.247
26. Nieman DH, Dragt S, van Duin ED, Denneman N, Overbeek JM, de Haan L, Rietdijk J, Ising HK et al (2016) COMT Val(158)Met genotype and cannabis use in people with an at risk mental state for psychosis: exploring gene x environment interactions. Schizophr Res 174(1–3):24–28. doi:10.1016/j.schres.2016.03.015
27. Ursini G, Cavalleri T, Fazio L, Angrisano T, Iacovelli L, Porcelli A, Maddalena G, Punzi G et al (2016) BDNF rs6265 methylation and genotype interact on risk for schizophrenia. Epigenetics 11(1):11–23. doi:10.1080/15592294.2015.1117736
28. McNeil TF, Cantor-Graae E, Torrey EF, Sjostrom K, Bowler A, Taylor E, Rawlings R, Higgins ES (1994) Obstetric complications in histories of monozygotic twins discordant and concordant for schizophrenia. Acta Psychiatr Scand 89(3):196–204
29. Colizzi M, Iyegbe C, Powell J, Ursini G, Porcelli A, Bonvino A, Taurisano P, Romano R et al (2015) Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis. Schizophr Bull 41(5):1171–1182. doi:10.1093/schbul/sbv032
30. Ermis A, Erkiran M, Dasdemir S, Turkcan AS, Ceylan ME, Bireller ES, Cakmakoglu B (2015) The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia. In Vivo 29(1):129–132
31. Green MJ, Raudino A, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ (2015) Do common genotypes of FK506 binding protein 5 (FKBP5) moderate the effects of childhood maltreatment on cognition in schizophrenia and healthy controls? J Psychiatr Res 70:9–17. doi:10.1016/j.jpsychires.2015.07.019
32. Wegelius A, Pankakoski M, Tomppo L, Lehto U, Lonnqvist J, Suvisaari J, Paunio T, Hennah W (2015) An interaction between NDE1 and high birth weight increases schizophrenia susceptibility. Psychiatry Res 230(2):194–199. doi:10.1016/j.psychres.2015.08.038
33. Aas M, Haukvik UK, Djurovic S, Tesli M, Athanasiu L, Bjella T, Hansson L, Cattaneo A et al (2014) Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. J Psychiatr Res 59:14–21. doi:10.1016/j.jpsychires.2014.08.011
34. Ajnakina O, Borges S, Di Forti M, Patel Y, Xu X, Green P, Stilo SA, Kolliakou A et al (2014) Role of environmental confounding in the association between FKBP5 and first-episode psychosis. Front Psych 5:84. doi:10.3389/fpsyt.2014.00084
35. Hernaus D, van Winkel R, Gronenschild E, Habets P, Kenis G, Marcelis M, van Os J, Myin-Germeys I et al (2014) Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance. PLoS One 9(3):e92722. doi:10.1371/journal.pone.0092722
36. McCarthy-Jones S, Green MJ, Scott RJ, Tooney PA, Cairns MJ, Wu JQ, Oldmeadow C, Carr V (2014) Preliminary evidence of an interaction between the FOXP2 gene and childhood emotional abuse predicting likelihood of auditory verbal hallucinations in schizophrenia. J Psychiatr Res 50:66–72. doi:10.1016/j.jpsychires.2013.11.012
37. Pishva E, Drukker M, Viechtbauer W, Decoster J, Collip D, van Winkel R, Wichers M, Jacobs N et al (2014) Epigenetic genes and emotional reactivity to daily life events: a multi-step gene-environment interaction study. PLoS One 9(6):e100935. doi:10.1371/journal.pone.0100935
38. Collip D, Myin-Germeys I, Wichers M, Jacobs N, Derom C, Thiery E, Lataster T, Simons C et al (2013) FKBP5 as a possible moderator of the psychosis-inducing effects of childhood trauma. Br J Psychiatry 202(4):261–268. doi:10.1192/bjp.bp.112.115972
39. De Sousa KR, Tiwari AK, Giuffra DE, Mackenzie B, Zai CC, Kennedy JL (2013) Age at onset of schizophrenia: cannabis, COMT gene, and their interactions. Schizophr Res 151(1–3):289–290. doi:10.1016/j.schres.2013.10.037
40. Onwuameze OE, Nam KW, Epping EA, Wassink TH, Ziebell S, Andreasen NC, Ho BC (2013) MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med 43(3):619–631. doi:10.1017/S0033291712001559
41. Ramsay H, Kelleher I, Flannery P, Clarke MC, Lynch F, Harley M, Connor D, Fitzpatrick C et al (2013) Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample. PLoS One 8(11):e79741. doi:10.1371/journal.pone.0079741
42. Vinkers CH, Van Gastel WA, Schubart CD, Van Eijk KR, Luykx JJ, Van Winkel R, Joels M, Ophoff RA et al (2013) The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val(1)(5)(8)Met polymorphism. Schizophr Res 150(1):303–311. doi:10.1016/j.schres.2013.07.020
43. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Prata D, Williams S, Brammer M et al (2012) Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry 17(12):1152–1155. doi:10.1038/mp.2011.187
44. Di Forti M, Iyegbe C, Sallis H, Kolliakou A, Falcone MA, Paparelli A, Sirianni M, La Cascia C et al (2012) Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry 72(10):811–816. doi:10.1016/j.biopsych.2012.06.020
45. Husted JA, Ahmed R, Chow EW, Brzustowicz LM, Bassett AS (2012) Early environmental exposures influence schizophrenia expression even in the presence of strong genetic predisposition. Schizophr Res 137(1–3):166–168. doi:10.1016/j.schres.2012.02.009
46. Peerbooms O, Rutten BP, Collip D, Lardinois M, Lataster T, Thewissen V, Rad SM, Drukker M et al (2012) Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. Acta Psychiatr Scand 125(3):247–256. doi:10.1111/j.1600-0447.2011.01806.x
47. Alemany S, Arias B, Aguilera M, Villa H, Moya J, Ibanez MI, Vossen H, Gasto C et al (2011) Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. Br J Psychiatry 199(1):38–42. doi:10.1192/bjp.bp.110.083808
48. Collip D, van Winkel R, Peerbooms O, Lataster T, Thewissen V, Lardinois M, Drukker M, Rutten BP et al (2011) COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. CNS Neurosci Ther 17(6):612–619. doi:10.1111/j.1755-5949.2010.00213.x
49. Costas J, Sanjuan J, Ramos-Rios R, Paz E, Agra S, Tolosa A, Paramo M, Brenlla J et al (2011) Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res 127(1–3):22–27. doi:10.1016/j.schres.2011.01.014
50. Decoster J, van Os J, Kenis G, Henquet C, Peuskens J, De Hert M, van Winkel R (2011) Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. Am J Med Genet B Neuropsychiatr Genet 156B(3):363–369. doi:10.1002/ajmg.b.31174
51. Demontis D, Nyegaard M, Buttenschon HN, Hedemand A, Pedersen CB, Grove J, Flint TJ, Nordentoft M et al (2011) Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk. Am J Med Genet B Neuropsychiatr Genet 156B(8):913–922. doi:10.1002/ajmg.b.31234
52. Estrada G, Fatjo-Vilas M, Munoz MJ, Pulido G, Minano MJ, Toledo E, Illa JM, Martin M et al (2011) Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand 123(6):485–492. doi:10.1111/j.1600-0447.2010.01665.x
53. Ho BC, Wassink TH, Ziebell S, Andreasen NC (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128(1–3):66–75. doi:10.1016/j.schres.2011.02.021
54. Muntjewerff JW, Ophoff RA, Buizer-Voskamp JE, Strengman E, den Heijer M, Consortium G (2011) Effects of season of birth and a common MTHFR gene variant on the risk of schizophrenia. Eur Neuropsychopharmacol J Eur College Neuropsychopharmacol 21(4):300–305. doi:10.1016/j.euroneuro.2010.10.001
55. van Winkel R (2011) Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 68(2):148–157. doi:10.1001/archgenpsychiatry.2010.152
56. Haukvik UK, Saetre P, McNeil T, Bjerkan PS, Andreassen OA, Werge T, Jonsson EG, Agartz I (2010) An exploratory model for G x E interaction on hippocampal volume in schizophrenia; obstetric complications and hypoxia-related genes. Prog Neuro-Psychopharmacol Biol Psychiatry 34(7):1259–1265. doi:10.1016/j.pnpbp.2010.07.001
57. Pelayo-Teran JM, Perez-Iglesias R, Mata I, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B (2010) Catechol-O-methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications. Psychiatry Res 179(3):291–296. doi:10.1016/j.psychres.2009.08.022
58. Zammit S, Lewis G, Dalman C, Allebeck P (2010) Examining interactions between risk factors for psychosis. Br J Psychiatry 197(3):207–211. doi:10.1192/bjp.bp.109.070904
59. Gutierrez B, Rivera M, Obel L, McKenney K, Martinez-Leal R, Molina E, Dolz M, Ochoa S et al (2009) Variability in the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption. Rev Psiquiatr Salud Ment 2(2):89–94. doi:10.1016/S1888-9891(09)72250-5
60. Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, van Os J, Myin-Germeys I (2009) COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life. Acta Psychiatr Scand 119(2):156–160. doi:10.1111/j.1600-0447.2008.01265.x
61. Kantrowitz JT, Nolan KA, Sen S, Simen AA, Lachman HM, Bowers MB Jr (2009) Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians. Psychiatry Q 80(4):213–218. doi:10.1007/s11126-009-9108-4
62. Keri S, Kiss I, Seres I, Kelemen O (2009) A polymorphism of the neuregulin 1 gene (SNP8NRG243177/rs6994992) affects reactivity to expressed emotion in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 150B(3):418–420. doi:10.1002/ajmg.b.30812
63. Simons CJ, Wichers M, Derom C, Thiery E, Myin-Germeys I, Krabbendam L, van Os J (2009) Subtle gene-environment interactions driving paranoia in daily life. Genes Brain Behav 8(1):5–12. doi:10.1111/j.1601-183X.2008.00434.x
64. Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, Weinberger DR (2008) Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry 13(9):873–877. doi:10.1038/sj.mp.4002153
65. van Winkel R, Henquet C, Rosa A, Papiol S, Fananas L, De Hert M, Peuskens J, van Os J et al (2008) Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet 147B(1):10–17. doi:10.1002/ajmg.b.30559
66. Shirts BH, Kim JJ, Reich S, Dickerson FB, Yolken RH, Devlin B, Nimgaonkar VL (2007) Polymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia risk. Schizophr Res 94(1–3):342–353. doi:10.1016/j.schres.2007.04.021
67. Stefanis NC, Henquet C, Avramopoulos D, Smyrnis N, Evdokimidis I, Myin-Germeys I, Stefanis CN, Van Os J (2007) COMT Val158Met moderation of stress-induced psychosis. Psychol Med 37(11):1651–1656. doi:10.1017/S0033291707001080
68. Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (2007) Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 191:402–407. doi:10.1192/bjp.bp.107.036129
69. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M, Ramaekers JG, van Os J (2006) An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31(12):2748–2757. doi:10.1038/sj.npp.1301197
70. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L et al (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57(10):1117–1127. doi:10.1016/j.biopsych.2005.01.026
71. Chotai J, Serretti A, Lattuada E, Lorenzi C, Lilli R (2003) Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms. Psychiatry Res 119(1–2):99–111
72. Tochigi M, Ohashi J, Umekage T, Kohda K, Hibino H, Otowa T, Marui T, Masui K et al (2002) Human leukocyte antigen-A specificities and its relation with season of birth in Japanese patients with schizophrenia. Neurosci Lett 329(2):201–204
73. Narita K, Sasaki T, Akaho R, Okazaki Y, Kusumi I, Kato T, Hashimoto O, Fukuda R et al (2000) Human leukocyte antigen and season of birth in Japanese patients with schizophrenia. Am J Psychiatry 157(7):1173–1175. doi:10.1176/appi.ajp.157.7.1173
74. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM et al (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39(11–12):964–971. doi:10.1111/j.1440-1614.2005.01714.x
75. Konings M, Bak M, Hanssen M, van Os J, Krabbendam L (2006) Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 114(1):55–61. doi:10.1111/j.1600-0447.2005.00741.x
76. Rosenman S, Rodgers B (2004) Childhood adversity in an Australian population. Soc Psychiatry Psychiatr Epidemiol 39(9):695–702. doi:10.1007/s00127-004-0802-0
77. Andreasen NC, Flaum M, Arndt S (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49(8):615–623
78. Bifulco A, Bernazzani O, Moran PM, Jacobs C (2005) The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. Br J Clin Psychol 44(Pt 4):563–581. doi:10.1348/014466505X35344
79. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S et al (2009) High-potency cannabis and the risk of psychosis. Br J Psychiatry 195(6):488–491. doi:10.1192/bjp.bp.109.064220
80. Andrews G, Peters L (1998) The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol 33(2):80–88
81. Loonstra AS, Tarlow AR, Sellers AH (2001) COWAT metanorms across age, education, and gender. Appl Neuropsychol 8(3):161–166. doi:10.1207/S15324826AN0803_5
82. Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J (1994) Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 151(8):1132–1136. doi:10.1176/ajp.151.8.1132
83. Castle DJ, Jablensky A, McGrath JJ, Carr V, Morgan V, Waterreus A, Valuri G, Stain H et al (2006) The diagnostic interview for psychoses (DIP): Development, reliability and applications. Psychol Med 36(1):69–80. doi:10.1017/S0033291705005969
84. Robins LN, Cottler L, Bucholtz K, Compton W (1995) Diagnostic Interview Schedule for DSM-IV. St. Louis, MO: Department of Psychiatry, Washington University School of Medicine
85. Moreno S, Rodriguez S, Fernandez MC, Tamez J, Cepeda-Benito A (2008) Clinical validation of the trait and state versions of the Food Craving Questionnaire. Assessment 15(3):375–387. doi:10.1177/1073191107312651
86. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
87. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N (1996) The Schedule for Affective Disorders and Schizophrenia for School Aged Children: present and lifetime version. University of Pittsburgh: Western Psychiatric Institute and Clinic, Pittsburg
88. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33 quiz 34-57
89. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276
90. McGuffin P, Farmer A, Harvey I (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48(8):764–770
91. Rosenfarb IS, Goldstein MJ, Mintz J, Nuechterlein KH (1995) Expressed emotion and subclinical psychopathology observable within the transactions between schizophrenic patients and their family members. J Abnorm Psychol 104(2):259–267
92. Rosenfarb IS, Nuechterlein KH, Goldstein MJ, Subotnik KL (2000) Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Arch Gen Psychiatry 57(12):1174–1179
93. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
94. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20(3):310–319. doi:10.1076/jcen.20.3.310.823
95. First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press, Inc., Washington
96. Kendler KS, Lieberman JA, Walsh D (1989) The Structured Interview for Schizotypy (SIS): a preliminary report. Schizophr Bull 15(4):559–571
97. Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17(4):555–564
98. Holmes TH, Rahe RH (1967) The Social Readjustment Rating Scale. J Psychosom Res 11(2):213–218
99. Wechsler D (1997) Weschsler Adult Intelligence Scale-III. The Psychological Corporation, San Antonio
100. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Leister F, Krivogorsky B, Yolken RH (2006) The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord 8(2):124–132. doi:10.1111/j.1399-5618.2006.00288.x
101. De Pradier M, Gorwood P, Beaufils B, Ades J, Dubertret C (2010) Influence of the serotonin transporter gene polymorphism, cannabis and childhood sexual abuse on phenotype of bipolar disorder: a preliminary study. Eur Psychiatry 25(6):323–327. doi:10.1016/j.eurpsy.2009.10.002
102. Hosang GM, Uher R, Keers R, Cohen-Woods S, Craig I, Korszun A, Perry J, Tozzi F et al (2010) Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 125(1–3):345–349. doi:10.1016/j.jad.2010.01.071
103. Savitz J, van der Merwe L, Newman TK, Stein DJ, Ramesar R (2010) Catechol-o-methyltransferase genotype and childhood trauma may interact to impact schizotypal personality traits. Behav Genet 40(3):415–423. doi:10.1007/s10519-009-9323-7
104. Debnath M, Busson M, Jamain S, Etain B, Hamdani N, Oliveira J, Boukouaci W, Amokrane K et al (2013) The HLA-G low expressor genotype is associated with protection against bipolar disorder. Hum Immunol 74(5):593–597. doi:10.1016/j.humimm.2012.11.032
105. Miller S, Hallmayer J, Wang PW, Hill SJ, Johnson SL, Ketter TA (2013) Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. J Psychiatr Res 47(2):252–258. doi:10.1016/j.jpsychires.2012.10.015
106. Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S et al (2014) Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord 159:23–30. doi:10.1016/j.jad.2014.02.018
107. Breen ME, Seifuddin F, Zandi PP, Potash JB, Willour VL (2015) Investigating the role of early childhood abuse and HPA axis genes in suicide attempters with bipolar disorder. Psychiatr Genet 25(3):106–111. doi:10.1097/YPG.0000000000000082
108. Oliveira J, Etain B, Lajnef M, Hamdani N, Bennabi M, Bengoufa D, Sundaresh A, Chaabane AB et al (2015) Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders. PLoS One 10(3):e0119702. doi:10.1371/journal.pone.0119702
109. Zeni CP, Mwangi B, Cao B, Hasan KM, Walss-Bass C, Zunta-Soares G, Soares JC (2016) Interaction between BDNF rs6265 Met allele and low family cohesion is associated with smaller left hippocampal volume in pediatric bipolar disorder. J Affect Disord 189:94–97. doi:10.1016/j.jad.2015.09.031
110. Oliveira J, Kazma R, Le Floch E, Bennabi M, Hamdani N, Bengoufa D, Dahoun M, Manier C et al (2016) Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study. Int J Bipolar Disord 4(1):11. doi:10.1186/s40345-016-0052-6
111. Buss AH, Durkee A (1957) An inventory for assessing different kinds of hostility. J Consult Psychol 21(4):343–349
112. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1(2):131–139
113. Barratt ES (1965) Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep 16:547–554
114. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997) Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73(3):159–171
115. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D et al (1994) Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genet Initiat Arch Gen Psychiat 51(11):849–859 discussion 863-844
116. Boyd CP, Gullone E, Needleman GL, Burt T (1997) The Family Environment Scale: reliability and normative data for an adolescent sample. Fam Process 36(4):369–373
117. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
118. Brugha T, Bebbington P, Tennant C, Hurry J (1985) The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 15(1):189–194
119. Parker G (1979) Parental characteristics in relation to depressive disorders. Br J Psychiatry 134:138–147
120. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D et al (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47(6):589–593
121. Claridge G, Broks P (1984) Schizotypy and hemisphere function—I. Personal Individ Differ 5:633–648
122. Hooper LM, Stockton P, Krupnick JL, Green BL (2011) Development, Use, and Psychometric Properties of the Trauma History Questionnaire. J Loss Trauma 16(3):258–283
123. Alemany S, Moya J, Ibanez MI, Villa H, Mezquita L, Ortet G, Gasto C, Fananas L et al (2015) Research letter: childhood trauma and the rs1360780 SNP of FKBP5 gene in psychosis: a replication in two general population samples. Psychol Med:1–3. doi:10.1017/S0033291715001695
124. Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA (2013) Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr Bull 39(2):251–254. doi:10.1093/schbul/sbs188
125. Miller BJ, Culpepper N, Rapaport MH (2013) C-reactive protein levels in schizophrenia. Clin Schizophr Relat Psychoses:1–22. doi:10.3371/CSRP.MICU.020813
126. Kinnally EL, Huang YY, Haverly R, Burke AK, Galfalvy H, Brent DP, Oquendo MA, Mann JJ (2009) Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. Psychiatr Genet 19(3):126–133. doi:10.1097/YPG.0b013e32832a50a7
127. van Os J, Marcelis M (1998) The ecogenetics of schizophrenia: a review. Schizophr Res 32(2):127–135
128. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM et al (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5):807–821. doi:10.1086/425589
129. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L et al (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66(1):13–20. doi:10.1001/archgenpsychiatry.2008.514
130. Casadio P, Fernandes C, Murray RM, Di Forti M (2011) Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev 35(8):1779–1787. doi:10.1016/j.neubiorev.2011.04.007
131. Okimura T, Tanaka S, Maeda T, Kato M, Mimura M (2015) Simulation of the capacity and precision of working memory in the hypodopaminergic state: relevance to schizophrenia. Neuroscience 295:80–89. doi:10.1016/j.neuroscience.2015.03.039
132. Thomas D (2010) Gene–environment-wide association studies: emerging approaches. Nat Rev Genet 11(4):259–272. doi:10.1038/nrg2764
133. Manuck SB, McCaffery JM (2014) Gene-environment interaction. Ann Rev Psychol 65:41–70. doi:10.1146/annurev-psych-010213-115100
134. Liu CY, Maity A, Lin X, Wright RO, Christiani DC (2012) Design and analysis issues in gene and environment studies. Environ Health 11:93. doi:10.1186/1476-069X-11-93
135. Uher R (2008) Gene–environment interaction: overcoming methodological challenges. In: Rutter MJ (ed) Genetic effects on environmental vulnerability to disease. John Wiley & Sons Ltd, Chichester, pp. 13–26
136. Colman I, Kingsbury M, Garad Y, Zeng Y, Naicker K, Patten S, Jones PB, Wild TC et al (2016) Consistency in adult reporting of adverse childhood experiences. Psychol Med 46(3):543–549. doi:10.1017/S0033291715002032
137. McKinney CM, Harris TR, Caetano R (2009) Reliability of self-reported childhood physical abuse by adults and factors predictive of inconsistent reporting. Violence Vict 24(5):653–668
138. Fisher HL, Craig TK, Fearon P, Morgan K, Dazzan P, Lappin J, Hutchinson G, Doody GA et al (2011) Reliability and comparability of psychosis patients’ retrospective reports of childhood abuse. Schizophr Bull 37(3):546–553. doi:10.1093/schbul/sbp103
139. Wolke D, Lereya ST, Fisher HL, Lewis G, Zammit S (2014) Bullying in elementary school and psychotic experiences at 18 years: a longitudinal, population-based cohort study. Psychol Med 44(10):2199–2211. doi:10.1017/S0033291713002912
140. Cutajar MC, Mullen PE, Ogloff JR, Thomas SD, Wells DL, Spataro J (2010) Schizophrenia and other psychotic disorders in a cohort of sexually abused children. Arch Gen Psychiatry 67(11):1114–1119. doi:10.1001/archgenpsychiatry.2010.147
141. Arseneault L, Cannon M, Fisher HL, Polanczyk G, Moffitt TE, Caspi A (2011) Childhood trauma and children’s emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. Am J Psychiatry 168(1):65–72. doi:10.1176/appi.ajp.2010.10040567
142. Hardt J, Rutter M (2004) Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry 45(2):260–273
143. Selten JP, van der Ven E, Rutten BP, Cantor-Graae E (2013) The social defeat hypothesis of schizophrenia: an update. Schizophr Bull 39(6):1180–1186. doi:10.1093/schbul/sbt134
144. Houston JE, Murphy J, Adamson G, Stringer M, Shevlin M (2008) Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull 34(3):580–585. doi:10.1093/schbul/sbm127
145. Murphy J, Houston JE, Shevlin M, Adamson G (2013) Childhood sexual trauma, cannabis use and psychosis: statistically controlling for pre-trauma psychosis and psychopathology. Soc Psychiatry Psychiatr Epidemiol 48(6):853–861. doi:10.1007/s00127-012-0592-8
146. Padmanabhan JL, Shah JL, Neeraj T, Keshavan MS (2017) The “polyenviromic risk score”: aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects. Schizophr Res 181:17–22. doi:10.1016/j.schres.2016.10.014
147. Iyegbe C, Campbell D, Butler A, Ajnakina O, Sham P (2014) The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. Soc Psychiatry Psychiatr Epidemiol 49(2):169–182. doi:10.1007/s00127-014-0823-2
148. Misiak B, Frydecka D, Zawadzki M, Krefft M, Kiejna A (2014) Refining and integrating schizophrenia pathophysiology—relevance of the allostatic load concept. Neurosci Biobehav Rev 45C:183–201. doi:10.1016/j.neubiorev.2014.06.004
149. Marin O (2016) Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med 22(11):1229–1238. doi:10.1038/nm.4225
150. Davis J, Moylan S, Harvey BH, Maes M, Berk M (2014) Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries. Aust N Z J Psychiatr 48(6):512–529. doi:10.1177/0004867414533012
151. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM et al (2004) Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161(5):889–895. doi:10.1176/appi.ajp.161.5.889
152. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH (2001) Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15(4):411–420. doi:10.1006/brbi.2001.0644
153. Scola G, Duong A (2017) Prenatal maternal immune activation and brain development with relevance to psychiatric disorders. Neuroscience 346:403–408. doi:10.1016/j.neuroscience.2017.01.033
154. Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP (2012) An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry 17(12):1194–1205. doi:10.1038/mp.2011.183
155. Cannon TD, van Erp TG, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, Salonen O, Valanne L et al (2002) Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59(1):35–41
156. Haukvik UK, McNeil T, Lange EH, Melle I, Dale AM, Andreassen OA, Agartz I (2014) Pre- and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder. Psychol Med 44(5):975–985. doi:10.1017/S0033291713001529
157. Moran P, Stokes J, Marr J, Bock G, Desbonnet L, Waddington J, O’Tuathaigh C (2016) Gene x environment interactions in schizophrenia: evidence from genetic mouse models. Neural Plast 2016:2173748. doi:10.1155/2016/2173748
158. De Bellis MD, Zisk A (2014) The biological effects of childhood trauma. Child Adolesc Psychiatr Clin N Am 23(2):185–222, vii. doi:10.1016/j.chc.2014.01.002
159. Misiak B, Krefft M, Bielawski T, Moustafa AA, Sasiadek MM, Frydecka D (2017) Toward a unified theory of childhood trauma and psychosis: a comprehensive review of epidemiological, clinical, neuropsychological and biological findings. Neurosci Biobehav Rev 75:393–406. doi:10.1016/j.neubiorev.2017.02.015
160. Moustafa AA, Salama M, Peak R, Tindle R, Salem A, Keri S, Misiak B, Frydecka D et al (2017) Interactions between cannabis and schizophrenia in humans and rodents. Rev Neurosci. doi:10.1515/revneuro-2016-0083
161. Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J et al (2016) A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185–194. doi:10.1016/j.neubiorev.2016.03.017
162. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160(4):636–645. doi:10.1176/appi.ajp.160.4.636
163. Arfken CL, Carney S, Boutros NN (2009) Translating biological parameters into clinically useful diagnostic tests. Curr Psychiatry Rep 11(4):320–323
164. Thibaut F, Boutros NN, Jarema M, Oranje B, Hasan A, Daskalakis ZJ, Wichniak A, Schmitt A et al (2015) Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: neurophysiology. World J Biol Psychiatry 16(5):280–290. doi:10.3109/15622975.2015.1050061
165. Howes OD, Murray RM (2014) Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 383(9929):1677–1687. doi:10.1016/s0140-6736(13)62036-x
166. Barkus E, Morrison P, Di Forti M, Murray RM (2016) Are deficits in cognition associated with psychotic-like experiences after cannabis? Hum Psychopharmacol 31(6):402–411. doi:10.1002/hup.2556
167. Gawęda Ł, Prochwicz K, Adamczyk P, Frydecka D, Misiak B, Kotowicz K, Szczepanowski R, Florkowski M, Nelson B (2017) The role of self-disturbances and cognitive biases in the relationship between traumatic life events and psychosis proneness in a non-clinical sample. Schizophr Res. doi:10.1016/j.schres.2017.07.023
168. Bosia M, Pigoni A, Pirovano A, Lorenzi C, Spangaro M, Buonocore M, Bechi M, Cocchi F et al (2015) COMT and STH polymorphisms interaction on cognition in schizophrenia. Neurol Sci 36(2):215–220. doi:10.1007/s10072-014-1936-9
169. Lopez-Garcia P, Young Espinoza L, Molero Santos P, Marin J, Ortuno Sanchez-Pedreno F (2013) Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives. Psychiatry Res 208(2):118–124. doi:10.1016/j.psychres.2012.09.043
170. Green MJ, Chia TY, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ (2014) Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia. J Psychiatr Res 49:43–50. doi:10.1016/j.jpsychires.2013.10.018
171. Larson R, Csikszentmihalyi M (2014) The experience sampling method. In: Csikszentmihalyi M (ed) Flow and the foundations of positive psychology. Springer Netherlands, Dordrecht, pp. 21–34
172. Reininghaus U, Kempton MJ, Valmaggia L, Craig TK, Garety P, Onyejiaka A, Gayer-Anderson C, So SH et al (2016) Stress sensitivity, aberrant salience, and threat anticipation in early psychosis: an experience sampling study. Schizophr Bull 42(3):712–722. doi:10.1093/schbul/sbv190
173. Reininghaus U, Gayer-Anderson C, Valmaggia L, Kempton MJ, Calem M, Onyejiaka A, Hubbard K, Dazzan P et al (2016) Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling study. Psychol Med 46(13):2799–2813. doi:10.1017/S003329171600146X
174. van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, van Zelst C, Bruggeman R, Reininghaus U et al (2014) Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull 40(4):729–736. doi:10.1093/schbul/sbu069